S. K. AGARWAL ET AL.
Open Access IJOHNS
262
prognosis is dependent on the type of malignant mesen-
chymal component. [7] In accordance with the previous
literature, surgical therapy is the primary mode of treat-
ment of these lesions. Conservational operations are per-
formed when indicated. Various methods include con-
servation partial laryngectomies like vertical and hori-
zontal partial laryngectomies and in some cases more
radical surgeries like supracricoid partial laryngectomy
with cricohyoidpexy and total laryngectomies with or
without neck dissections are done primarily for hypo-
pharyngeal, supraglottic, advanced glottic and transglot-
tic tumors. Another mode of treatment is chemotherapy
and radiotherapy alone or combined with surgery. Con-
servational surgeries and non-surgical therapy are func-
tionally preservative methods but prognostically less
favourable methods. As the metastasis has been reported
for such type of carcinomas, it seems to be reasonable to
use combined therapy, as neck dissections are associated
with better cure rates, and elective neck dissection must
be performed at the time of the initial treatment of a non-
epithelial neoplasm, therefore the most common treat-
ment is definitive surgery of that organ complemented
with neck dissection in some cases by adjuvant chemo-
therapy and/ or radiotherapy [1,7- 9].
Prognosis of true carcinosarcoma of the hypopharynx
is very poor because it is very aggressive and highly me-
tastatic in nature, and most of the cases died due to dis-
tant metastasis to lungs. The exact prognosis of these
tumours is not known.
The most important prognostic factors appear to be
location {hypopharynx versus larynx and supraglottic
versus glottic}, the size of the tumor and the presence of
cervical metastasis.
In the present case, the tumour was excised from the
hypopharynx with the help of pulsed CO2 LASER with
modified radical neck dissection type 1, and postopera-
tive co ncu rrent radi othe rapy a nd c hemot hera py we re gi ven.
REFERENCES
[1] K. Luna-Ortiz and A. M. Taylor, “Supracricoid Partial
Laryngectomy as a Primary Treatment for Carcinosar-
coma of the Larynx,” Ear, Nose and Throat Journal, Vol.
85, No. 5, 2006, pp. 337-341.
[2] K. D. Olsen, J. E. Lewis and V. J. Suman, “Spindle Cell
Carcinoma of the Larynx and Hypopharynx,” Otolaryn-
gology—Head and Neck Surgery, Vol. 116, No. 1, 1997,
pp. 47-52.
http://dx.doi.org/10.1016/S0194-5998(97)70351-6
[3] J. C. Bull and O. F. Grimes, “Pul mo nary Carcinosarcom a ,”
Chest, Vol. 65, No. 1, 1974, pp. 9-12.
http://dx.doi.org/10.1378/chest.65.1.9
[4] J. T. Au, G. Sugiyama, H. Wang, A. Nicastri, D. Lee, W.
Ko and V. Tak, “Carcinosarcoma of the Esophagus—A
Rare Mixed Type of Tumour,” Journal of Strength and
Conditioning Research, Vol. 7, 2010, p. 7.
[5] P. R. Lambert, P. H. Ward and G. Berci, “Pseudosarcoma
of the Larynx,” Archives of Otola ryn gology , Vol. 106, 1980,
pp. 700-708.
http://dx.doi.org/10.1001/archotol.1980.00790350042012
[6] G. Randall, W. A. Alonso and J. H. Ogura, “Spindle Cell
Carcinoma [Pseudosarcoma] of the Larynx,” Archives of
Otolaryngology, Vol. 101, No. 1, 1975, pp. 63-66.
http://dx.doi.org/10.1001/archotol.1975.00780300067018
[7] F. Ianniello, E. Ferri, E. Armato, et al., “Carcinosarcoma
of the Larynx: Immnohistochemical Study, Clinical Con-
siderations, Therapeutic Strategies,” Acta Otorhinolaryn-
gologica Italica, Vol. 21, No. 3, 2001, pp. 192-197.
[8] D. Vie Vers, A. de Vito, K. Luna-Ortiz, et al., “Supracri-
coid Partial Laryngectomy for Non Squamous Cell Car-
cinoma of the Larynx,” Journal of Laryngology & Otol-
ogy, Vol. 115, No. 5, 2001, pp. 388-392.
[9] U. Srinivasan and G. V. Talyalkar, “True Carcinosarcoma
of the Larynx: A Case Report,” Journal of Laryngology
& Otology, Vol. 93, No. 10, 1979, pp. 1031-1035.
http://dx.doi.org/10.1017/S002221510008806X